![Saurabh Saha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Saurabh Saha
Directeur/Membre du Conseil chez
CLARIVATE PLC
Fortune : 337 790 $ au 31/07/2026
Profil
Saurabh Saha is the founder of BioMed Valley Discoveries, Inc., founded in 2008, where the title held was Chief Scientific Officer.
Current jobs include Chief Executive Officer at Centessa Pharmaceuticals LLC; Director at Capella Bioscience Ltd. since 2021; Director at Z Factor Ltd.; Director at ApcinteX Ltd.; Independent Director at Clarivate Plc since 2023; Director at Scorpion Therapeutics, Inc. since 2022; Director at The Johns Hopkins Hospital, Inc.; Director at Johns Hopkins Medicine, Inc.; Director at The Johns Hopkins University School of Medicine; and Associate Member at Harvard Medical School.
Former jobs include President, Chief Executive Officer & Director at Delinia, Inc. from 2016 to 2017; Chief Executive Officer & Director at Centessa Pharmaceuticals Holdings, Inc.; Chief Executive Officer & Director at Centessa Pharmaceuticals Plc from 2021 to 2026; Director & Head-New Indications Discovery Unit at Novartis, Inc.; Senior Vice President-Research & Development at Bristol Myers Squibb Co. from 2017 to 2021; and Chief Medical Officer at Synlogic Operating Co., Inc. Education includes graduate degree from the University of Oxford, undergraduate degree from California Institute of Technology, and doctorate from The Johns Hopkins University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CLARIVATE PLC 0,03% | 14/05/2026 | 170 601 ( 0,03% ) | 337 790 $ | 31/07/2026 |
Postes actifs de Saurabh Saha
| Sociétés | Poste | Début |
|---|---|---|
| CLARIVATE PLC | Directeur/Membre du Conseil | 04/05/2023 |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Directeur/Membre du Conseil | 04/04/2022 |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Johns Hopkins Medicine, Inc.
 Johns Hopkins Medicine, Inc. Hospital/Nursing ManagementHealth Services Operates a hostpital | Directeur/Membre du Conseil | - |
Centessa Pharmaceuticals, Inc.
 Centessa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Directeur Général | - |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Capella Bioscience Ltd.
 Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Develops novel medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease | Directeur/Membre du Conseil | 29/01/2021 |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Engages in research and development of therapeutic agents to treat alpha-1 antitrypsin deficiency | Directeur/Membre du Conseil | 29/01/2021 |
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology Manufactures novel hemophilia drugs | Directeur/Membre du Conseil | 29/01/2021 |
| ░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Saurabh Saha
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Saurabh Saha
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins Hospital, Inc.
 The Johns Hopkins Hospital, Inc. Hospital/Nursing ManagementHealth Services Operates as a community hospital | Health Services |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johns Hopkins Medicine, Inc.
Johns Hopkins Medicine, Inc. Hospital/Nursing ManagementHealth Services Operates a hostpital | Health Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Capella Bioscience Ltd.
Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Develops novel medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease | Health Technology |
Delinia, Inc.
 Delinia, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases | Health Technology |
Z Factor Ltd.
Z Factor Ltd. BiotechnologyHealth Technology Engages in research and development of therapeutic agents to treat alpha-1 antitrypsin deficiency | Health Technology |
ApcinteX Ltd.
ApcinteX Ltd. BiotechnologyHealth Technology Manufactures novel hemophilia drugs | Health Technology |
BioMed Valley Discoveries, Inc.
 BioMed Valley Discoveries, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops therapies for cancer, inflammation and infectious disease | Commercial Services |
Clarivate Plc
 Clarivate Plc Miscellaneous Commercial ServicesCommercial Services Provides information, analytics and workflow solutions | Commercial Services |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Health Technology |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
Centessa Pharmaceuticals, Inc.
Centessa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
Centessa Pharmaceuticals Holdings, Inc.
 Centessa Pharmaceuticals Holdings, Inc. Pharmaceuticals: OtherHealth Technology Designs and develops medicines | Health Technology |
